Clinical Trial Update: A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating two 3-dose schedules of a Clostridium difficile vaccine in healthy adults aged 65-85; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Pfizer C. difficile vaccine

Snippet

Sponsor: Pfizer | Conditions: Clostridium Difficile Associated Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-03-30